Funder
Tehran University of Medical Sciences and Health Services
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Akhondzadeh S (2001) The 5-HT hypothesis of schizophrenia. Idrugs 4(3):295–300
2. Akhondzadeh S, Mohammadi MR, Amini-Nooshabadi H, Davari-Ashtiani R (1999) Cyproheptadine in treatment of chronic schizophrenia:a double-blind, placebo-controlled study. J Clin Pharm Ther 24:49–52
3. Association WM (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191–2194
4. Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, Bogerts B, Braun K, Jankowski Z, Kumaratilake J, Henneberg M, Gos T (2014) The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue. Front Psychiatry 5:47
5. Chouinard G, Margolese HC (2005) Manual for the extrapyramidal symptom rating scale (ESRS). Schizophr Res 76:247–265